DJ Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Incyte Corp. $(INCY)$ rose 1.64% to $122.27 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.31% to 7,619.38 and the Dow Jones Industrial Average rising 0.49% to 52,486.49.
Incyte Corp. closed 7.79% short of its 52-week high of $132.60, which the company achieved on July 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 5.41% to $159.85, Bio-Techne Corp. (TECH) fell 0.03% to $72.80, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 2.10% to $58.33.
Trading volume (1.2 M) remained 552,275 below its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 11, 2026.
Comments